259 related articles for article (PubMed ID: 35285617)
1. Organotropic Targeting of Biomimetic Nanoparticles to Treat Lung Disease.
Holay M; Zhou J; Park JH; Landa I; Ventura CJ; Gao W; Fang RH; Zhang L
Bioconjug Chem; 2022 Apr; 33(4):586-593. PubMed ID: 35285617
[TBL] [Abstract][Full Text] [Related]
2. Biomimetic particles as therapeutics.
Meyer RA; Sunshine JC; Green JJ
Trends Biotechnol; 2015 Sep; 33(9):514-524. PubMed ID: 26277289
[TBL] [Abstract][Full Text] [Related]
3. Advances in Biomimetic Nanoparticles for Targeted Cancer Therapy and Diagnosis.
Beh CY; Prajnamitra RP; Chen LL; Hsieh PC
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443638
[TBL] [Abstract][Full Text] [Related]
4. Recent Advances of Membrane-Cloaked Nanoplatforms for Biomedical Applications.
Ai X; Hu M; Wang Z; Zhang W; Li J; Yang H; Lin J; Xing B
Bioconjug Chem; 2018 Apr; 29(4):838-851. PubMed ID: 29509403
[TBL] [Abstract][Full Text] [Related]
5. Cell membrane-camouflaged nanoparticles for drug delivery.
Luk BT; Zhang L
J Control Release; 2015 Dec; 220(Pt B):600-7. PubMed ID: 26210440
[TBL] [Abstract][Full Text] [Related]
6. Biomimetic Nanotechnology toward Personalized Vaccines.
Zhou J; Kroll AV; Holay M; Fang RH; Zhang L
Adv Mater; 2020 Apr; 32(13):e1901255. PubMed ID: 31206841
[TBL] [Abstract][Full Text] [Related]
7. Stem cell membrane-coated abiotic nanomaterials for biomedical applications.
Ferreira-Faria I; Yousefiasl S; Macário-Soares A; Pereira-Silva M; Peixoto D; Zafar H; Raza F; Faneca H; Veiga F; Hamblin MR; Tay FR; Gao J; Sharifi E; Makvandi P; Paiva-Santos AC
J Control Release; 2022 Nov; 351():174-197. PubMed ID: 36103910
[TBL] [Abstract][Full Text] [Related]
8. The potential of biomimetic nanoparticles for tumor-targeted drug delivery.
Li B; Wang F; Gui L; He Q; Yao Y; Chen H
Nanomedicine (Lond); 2018 Aug; 13(16):2099-2118. PubMed ID: 30226404
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in biomimetic nanodelivery systems: New brain-targeting strategies.
Liao J; Fan L; Li Y; Xu QQ; Xiong LY; Zhang SS; Liu JH; Xiao ZC; Zhang C; Yang J; Chen ZS; Xiao K; Wang TF; Lu Y
J Control Release; 2023 Jun; 358():439-464. PubMed ID: 37169179
[TBL] [Abstract][Full Text] [Related]
10. Recent Advances in Cell Membrane-Derived Biomimetic Nanotechnology for Cancer Immunotherapy.
Raza F; Zafar H; Zhang S; Kamal Z; Su J; Yuan WE; Mingfeng Q
Adv Healthc Mater; 2021 Mar; 10(6):e2002081. PubMed ID: 33586322
[TBL] [Abstract][Full Text] [Related]
11. Cell membrane biomimetic nanoparticles for inflammation and cancer targeting in drug delivery.
Wang H; Liu Y; He R; Xu D; Zang J; Weeranoppanant N; Dong H; Li Y
Biomater Sci; 2020 Jan; 8(2):552-568. PubMed ID: 31769765
[TBL] [Abstract][Full Text] [Related]
12. Tumor microenvironment-activated cancer cell membrane-liposome hybrid nanoparticle-mediated synergistic metabolic therapy and chemotherapy for non-small cell lung cancer.
Zhang W; Gong C; Chen Z; Li M; Li Y; Gao J
J Nanobiotechnology; 2021 Oct; 19(1):339. PubMed ID: 34689761
[TBL] [Abstract][Full Text] [Related]
13. Advances in cell membrane-based biomimetic nanodelivery systems for natural products.
Zhang Y; Zhang Q; Li C; Zhou Z; Lei H; Liu M; Zhang D
Drug Deliv; 2024 Dec; 31(1):2361169. PubMed ID: 38828914
[TBL] [Abstract][Full Text] [Related]
14. Enhancing Inflammation Targeting Using Tunable Leukocyte-Based Biomimetic Nanoparticles.
Zinger A; Sushnitha M; Naoi T; Baudo G; De Rosa E; Chang J; Tasciotti E; Taraballi F
ACS Nano; 2021 Apr; 15(4):6326-6339. PubMed ID: 33724785
[TBL] [Abstract][Full Text] [Related]
15. Biomimetic nanoarchitecturing: A disguised attack on cancer cells.
Jha A; Nikam AN; Kulkarni S; Mutalik SP; Pandey A; Hegde M; Rao BSS; Mutalik S
J Control Release; 2021 Jan; 329():413-433. PubMed ID: 33301837
[TBL] [Abstract][Full Text] [Related]
16. Bio-inspired engineering of cell- and virus-like nanoparticles for drug delivery.
Parodi A; Molinaro R; Sushnitha M; Evangelopoulos M; Martinez JO; Arrighetti N; Corbo C; Tasciotti E
Biomaterials; 2017 Dec; 147():155-168. PubMed ID: 28946131
[TBL] [Abstract][Full Text] [Related]
17. Stem cell membrane, stem cell-derived exosomes and hybrid stem cell camouflaged nanoparticles: A promising biomimetic nanoplatforms for cancer theranostics.
Khosravi N; Pishavar E; Baradaran B; Oroojalian F; Mokhtarzadeh A
J Control Release; 2022 Aug; 348():706-722. PubMed ID: 35732250
[TBL] [Abstract][Full Text] [Related]
18. Biomimetic Targeting of Nanoparticles to Immune Cell Subsets via Cognate Antigen Interactions.
Luk BT; Jiang Y; Copp JA; Hu CJ; Krishnan N; Gao W; Li S; Fang RH; Zhang L
Mol Pharm; 2018 Sep; 15(9):3723-3728. PubMed ID: 29533668
[TBL] [Abstract][Full Text] [Related]
19. From blood to brain: blood cell-based biomimetic drug delivery systems.
Li YJ; Wu JY; Liu J; Qiu X; Xu W; Tang T; Xiang DX
Drug Deliv; 2021 Dec; 28(1):1214-1225. PubMed ID: 34142628
[TBL] [Abstract][Full Text] [Related]
20. Recent progress in therapeutic strategies and biomimetic nanomedicines for rheumatoid arthritis treatment.
Li C; Zheng X; Hu M; Jia M; Jin R; Nie Y
Expert Opin Drug Deliv; 2022 Aug; 19(8):883-898. PubMed ID: 35760767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
